TRLV Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $10.72
Market Cap (MRQ) $2.06B
EPS $-0.58
Revenue $1.18B
ROE -10.4%
Debt/Equity (MRQ) 0.0
52W Range $8–$13

TRLV Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$1.18B
2019-12-31 → 2025-12-31
EPS$-0.58
2019-12-31 → 2025-12-31
Free Cash Flow$229M
2021-12-31 → 2025-12-31
Net margin-41.8%
2021-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend TRLV 5Y avg Peer Median Verdict
P/S (TTM) 1.8 · · ·
P/B (MRQ) 2.7 · · ·
Price / FCF (TTM) 10.6 · · ·
Price / Cash Flow (TTM) 8.4 · · ·
Price / Tangible Book (MRQ) 4.4 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -691.3%
Next Report Nov 03, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 7, 2026 $-2.10 $0.06 -3386.4%
March 31, 2026 $0.01 $-0.02 165.4%
Dec. 31, 2025 $-0.23 $-0.02 -866.4%
Sept. 30, 2025 $-0.14 $-0.09 -52.5%
June 30, 2025 $-0.07 $-0.07 -5.6%
Dec. 31, 2024 $-0.27 $-0.26 -2.6%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 17
Metric Trend 2025202420232022202120202019
Revenue $1.18B$1.19B$1.13B$1.22B$932M$522M$253M
Cost of Revenue $470M$471M$541M$529M$365M$135M$61M
Gross Profit $711M$716M$589M$689M$567M$386M$192M
SG&A Expense $445M$510M$386M$169M$99M$36M$14M
Operating Expenses $568M$618M$810M$639M$363M$168M$79M
Operating Income $143M$98M$-222M$50M$204M$218M$113M
Interest Expense ··$82M$73M$29M$20M$9M
Interest Income ··$6M$2M$205.0K··
Other Non-op $-1M$-8M$7M$2M$1M$2M$266.0K
Pretax Income $91M$43M$-285M$-19M$176M$157M$104M
Income Tax $208M$198M$151M$163M$146M$94M$51M
Net Income $-122M$-161M$-533M$-253M$17M$63M$53M
EPS (Basic) $-0.58$-0.79$-2.28$-0.95$0.22$0.55$0.48
EPS (Diluted) $-0.58$-0.79$-2.28$-0.95$0.21$0.53$0.46
Shares (Basic) 191,323,791189,992,663188,974,176187,995,317139,366,940113,572,379110,206,103
Shares (Diluted) 191,323,791189,992,663188,974,176187,995,317146,757,286118,325,724115,317,942
EBITDA $143M$98M$-222M$32M$197M··
Balance Sheet 28
Metric Trend 2025202420232022202120202019
Cash & Equivalents $256M$239M$201M$207M$227M$147M$92M
Short-term Investments $0$60M$0····
Receivables $10M$8M$7M$7M$9M$308.0K·
Inventory $242M$231M$213M$277M$212M$98M·
Prepaid Expense $18M$23M$18M$11M$68M$16M·
Other Current Assets $25M$26M$24M$51M$12M$3M·
Current Assets $563M$605M$477M$594M$524M$261M·
PP&E (Net) $670M$716M$676M$743M$780M$314M·
PP&E (Gross) $1.02B$987M$876M$869M$844M$344M·
Accum. Depreciation $346M$271M$199M$126M$64M$30M·
Goodwill $484M$484M$484M$791M$765M$67M$7M
Intangibles $798M$859M$917M$985M$1.12B$93M$30M
Other Non-current Assets $10M$20M$10M$13M$18M$8M·
Total Assets $2.70B$2.87B$2.73B$3.40B$3.41B$810M·
Accounts Payable $83M$20M$28M$16M$15M$9M·
Short-term Debt $4M$3M$4M$12M$10M$2M·
Current Liabilities $127M$138M$115M$210M$169M$76M·
Capital Leases $108M$117M$92M$100M$122M$28M·
Deferred Tax $178M$197M$207M$225M$251M$15M·
Other Non-current Liabilities $11M$5M$7M$7M$8M$4M·
Total Liabilities $1.55B$1.62B$1.32B$1.47B$1.26B$362M·
Long-term Debt $137M$365M$363M$542M$463M··
Total Debt $4M$3M$4M$12M$10M··
Common Stock $0$0$0$0···
Retained Earnings $-912M$-796M$-641M$-114M$138M$120M·
Stockholders' Equity $1.14B$1.25B$1.41B$1.93B$2.15B$448M$133M
Liabilities + Equity $2.70B$2.87B$2.73B$3.40B$3.41B$810M·
Shares Outstanding 192,307,145191,005,940186,235,818185,987,512180,504,172119,573,998·
Cash Flow 12
Metric Trend 2025202420232022202120202019
D&A $118M$113M$110M$116M$46M$13M$5M
Stock-based Comp $20M$20M$11M$18M$9M$3M·
Deferred Tax $-18M$-10M$-17M$-27M$-26M$-5M$-908.0K
Amort. of Intangibles $83M$82M$80M$82M$28M$3M$2M
Operating Cash Flow $273M$271M$202M$23M$13M$100M$19M
CapEx $44M$123M$40M$165M$276M$100M$72M
Investing Cash Flow $14M$-207M$-37M$-215M$-215M$-175M$-95M
Financing Cash Flow $-270M$-33M$-176M$178M$289M$130M$143M
Net Change in Cash $16M$31M$-11M$-14M$87M$55M$67M
Taxes Paid $1M$-48M$53M$147M$179M··
Free Cash Flow $229M$150M$161M$-142M$-263M··
Levered FCF ··$36M$-519M$-267M··
Profitability 8
Metric Trend 2025202420232022202120202019
Gross Margin 60.2%60.3%52.1%55.0%60.3%··
Operating Margin 12.2%8.2%-19.6%2.6%21.0%··
Net Margin -10.3%-13.5%-47.2%-20.4%1.9%··
Pretax Margin 7.7%3.6%-25.2%-3.5%17.4%··
EBITDA Margin 12.2%8.2%-19.6%2.6%21.0%··
ROA -4.4%-5.7%-17.4%-7.4%0.76%··
ROE -10.4%-12.6%-37.4%-12.8%1.2%··
ROIC -16.0%-28.3%-24.0%7.9%0.97%··
Liquidity & Solvency 4
Metric Trend 2025202420232022202120202019
Current Ratio 4.44.44.22.83.1··
Quick Ratio 2.12.21.81.11.4··
Debt / Equity 0.00.00.00.00.0··
Interest Coverage ··-2.70.45.7··
Efficiency 3
Metric Trend 2025202420232022202120202019
Asset Turnover 0.40.40.40.40.4··
Inventory Turnover 2.02.12.22.22.4··
Receivables Turnover 125.8158.3171.0135.5204.8··
Per Share 5
Metric Trend 2025202420232022202120202019
Book Value / Share $5.94$6.54$7.56$10.36$11.90··
Revenue / Share $6.17$6.24$5.98$6.59$6.39··
Cash Flow / Share $1.43$1.43$1.07$0.12$0.09··
Cash / Share $1.33$1.25$1.08$1.14$1.28··
EPS (TTM) $-0.58$-0.79$-2.28$-0.95$0.21$0.53·
Growth Rates 5
Metric Trend 2025202420232022202120202019
Revenue YoY -0.45%5.1%-7.3%30.7%78.7%··
Revenue CAGR 3Y -1.0%8.4%29.4%····
Revenue CAGR 5Y 17.8%······
EPS YoY ····-60.4%··
Net Income YoY ····-72.3%··
Valuation (TTM) 2
Metric Trend 2025202420232022202120202019
Revenue TTM $1.18B$1.19B$1.13B$1.22B$932M$522M·
Net Income TTM $-122M$-161M$-533M$-253M$17M$63M·

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $1.18B $1.19B $1.13B $1.22B $932M
Gross Margin % 60.2% 60.3% 52.1% 55.0% 60.3%
Operating Margin % 12.2% 8.2% -19.6% 2.6% 21.0%
Net Income $-122M $-161M $-533M $-253M $17M
Diluted EPS $-0.58 $-0.79 $-2.28 $-0.95 $0.21

Company insiders 27 insiders · 17 officers · 10 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Kim A. Rivers Chairman and CEO June 26, 2026 S 1,476,913 0 7 $-14,661,355
Jan Reese Chief Financial Officer March 13, 2026 A 58,594 0 0 $0
Ryan Blust Interim CFO Aug. 12, 2025 A 77,038 0 0 $0
Wes Getman Chief Financial Officer Dec. 11, 2024 P 47,000 0 0 $0
Alex D'Amico Chief Financial Officer Dec. 29, 2022 F 82,869 0 0 $0
Jason Pernell President March 13, 2026 A 581,795 0 0 $0
Steven Matthew White President May 24, 2022 P 2,400,674 0 0 $0
Marie Zhang Chief Operating Officer March 25, 2025 A 58,800 0 0 $0
Brett R. Walsh Chief Accounting Officer March 13, 2026 A 140,305 0 0 $0
Christine Ann Hersey Chief Corp Affairs & Strategy March 13, 2026 A 143,767 0 0 $0
Nilyum Jhala Chief Technology Officer March 13, 2026 A 239,254 0 0 $0
Kyle Landrum Chief Production Officer March 13, 2026 A 258,776 0 0 $0
Eric Powers Chief Legal Officer March 13, 2026 A 245,311 0 0 $0
Joy Malivuk Chief Accounting Officer Dec. 1, 2025 F 74,289 0 0 $0
Timothy Morey Chief Sales Officer Dec. 1, 2025 F 174,709 0 0 $0
Gina Collins Chief Marketing Officer Aug. 12, 2025 A 188,916 0 0 $0
Rebecca L. Young Chief Accounting Officer Feb. 24, 2022 A 8,729 0 0 $0
Richard S. May Director March 13, 2026 A 593,534 0 0 $0
Peter Healy Director March 13, 2026 A 72,673 0 0 $0
Thad Beshears Director March 13, 2026 A 2,487,043 0 0 $0
Matthew J. Foulston Director March 13, 2026 A 34,767 0 0 $0
Susan Thronson Director March 13, 2026 A 64,543 0 0 $0
Jane Cecil Morreau Director March 13, 2026 A 65,778 0 0 $0
Thomas L Millner Director March 13, 2026 A 72,543 0 0 $0
Giannella Alvarez Director May 16, 2024 S 44,732 0 0 $0
George Hackney Director April 9, 2021 J · 0 0 $0
Telogia Pharm, LLC 10% owner April 9, 2021 J · 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

TRLV Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 13 analysts BUY
Median target $19.00 +77.2%
2 15.4% Strong Buy
10 76.9% Buy
1 7.7% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

7 analysts · 2026-10-04

Mean target $18.18 +69.6%

← Below all targets Current price $10.72
Low$15.00 Mean$18.18 High$21.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
TRLV · · -0.45% -10.3% -10.4% 60.2%
HRMY $2.16B 13.8 21.5% 18.3% 19.3% 77.2%
PBH $3.33B 15.2 -4.3% 17.5% 10.2% 54.7%
GPCR $14.78B -86.9 · · -12.3% ·
TRVI $1.61B -39.1 · · -22.4% ·
NUVB $3.03B -14.9 699.0% -325.3% -60.3% ·
SEPN $1.25B -25.3 4174.5% -106.4% -12.9% ·
ANIP $1.78B 23.8 43.8% 8.9% 16.6% ·
ETON $457M · 104.9% -5.8% -18.4% 53.5%
LLY · 46.8 44.7% 31.7% 101.2% ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 7, 2026